Furthermore, NRAS mutation occurred more frequently in distant metastasis tumors (12.2% vs 3.3%, P = 0.010), and different tumor stage showed a different NRAS mutation rate (P = 0.030). This evidence concerns the gene NRAS and neoplasm.